| Application no. and date | 15835924.0 (espacenet) (Federated) (European Patent Register), 20150827 | | Patent/reg. no. and date | DK/EP 3185957, 20220601 | | Publication date | 20170705 | | Priority no. and date | US 201462044100 P, 20140829, US 201562150596 P, 20150421 | | EP pub. no. and date |
EP 3185957 20170705 | | Effective date | | | Applicant/owner | Alnylam Pharmaceuticals, Inc., 675 West Kendall Street
Henri A. Termeer Square
Cambridge, MA 02142, US | | Applicant ref. no. | 167085/BT/GP | | Inventor | BETTENCOURT, Brian,
Cambridge,MA 02142, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/341 (2006.01) , A61K 31/41 (2006.01) , A61K 31/435 (2006.01) , A61K 31/495 (2006.01) , A61K 31/573 (2006.01) , A61P 25/02 (2006.01) , A61P 25/28 (2006.01) , A61P 9/00 (2006.01) | | Title | Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis | | Int. application no. | US2015047185 | | Int. publication no. | WO2016033326 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
